Tag: Research

  • Retaklik UK: What It Is, How the Pen Works & Where to Source It

    Retaklik UK: What It Is, How the Pen Works & Where to Source It

    You’ve come across the name Retaklik. Maybe you saw it on a research catalogue, maybe a colleague mentioned it in the same breath as retatrutide, or maybe you’re trying to figure out whether it’s a brand, a compound, or something else entirely. You’re not alone — the terminology around injectable research peptide formats can be genuinely confusing, and “Retaklik” sits right in the middle of that confusion.

    This guide cuts through it. We’ll cover exactly what Retaklik is, how the pen format works, how to read the click-dose system, how it differs from vial-based retatrutide, and what to look for when sourcing it in the UK for research applications.


    What Is Retaklik?

    Retaklik is a brand name for retatrutide (LY3437943) supplied in a multi-dose injection pen format. The active compound is identical to lyophilised retatrutide vials — a synthetic triple receptor agonist targeting GLP-1, GIP, and glucagon (GCGR) pathways simultaneously — but Retaklik delivers it pre-filled in a click-dial pen rather than requiring reconstitution with bacteriostatic water.

    Retatrutide itself is an investigational peptide currently in Phase 3 clinical trials (the TRIUMPH programme) by Eli Lilly. As a research compound available in the UK, it is supplied by specialist peptide laboratories under a research-use-only designation, and Retaklik is one of the pen-format presentations researchers are increasingly requesting.

    Key fact: The “klik” in Retaklik refers to the click-dial dosing mechanism on the pen itself. Each click of the dial dispenses a precise, fixed quantity of retatrutide solution — making dose consistency straightforward to maintain across a research protocol without the need for syringes and vials.


    Retaklik vs Retatrutide Vials — What’s the Difference?

    Both deliver the same compound. The difference is entirely in the format and the research workflow it suits.

    FeatureRetaklik PenRetatrutide Vial (Lyophilised)
    Reconstitution requiredNo — pre-filled solutionYes — BAC water needed
    Dose measurementClick dial (fixed per click)Syringe draw (calculated volume)
    Equipment neededPen + needle tip onlyBAC water, syringe, needle, vial
    Dose flexibilityClick increments onlyAny dose (full calculator control)
    Storage (unopened)Refrigerated (2–8°C)Freezer (-20°C) up to 24 months
    Ideal forConsistent weekly protocolsCustom dosing, titration flexibility

    For researchers running a fixed weekly schedule where dose consistency matters more than granular control, the Retaklik pen offers a more streamlined workflow. For protocols requiring precise sub-milligram titration or custom concentrations, lyophilised vials with a retatrutide calculator give more flexibility.


    Retaklik Pen Variants: 20mg, 40mg, and 60mg

    Retaklik research pens are typically available in three fill sizes — 20mg, 40mg, and 60mg. These refer to the total retatrutide content per pen, not the per-dose amount. The 40mg variant is the most commonly used in UK research settings, providing enough compound for extended study periods without requiring frequent reorders.

    Pen SizeTotal ContentDoses at 2mg/weekDoses at 5mg/weekDoses at 10mg/week
    20mg pen20mg retatrutide10 doses4 doses2 doses
    40mg pen40mg retatrutide20 doses8 doses4 doses
    60mg pen60mg retatrutide30 doses12 doses6 doses

    MyReta stocks the Retaklik 40mg pen, independently verified to 99%+ purity by Janoshik Analytical, with UK next-day delivery available.


    How to Dial Your Retaklik Dose — The Click System Explained

    The defining feature of the Retaklik pen is its click-dial mechanism. Unlike a syringe where you calculate volume, the pen delivers a fixed quantity per click. On standard Retaklik pens, 1 click = 1/6 mg (approximately 0.167 mg) of retatrutide, with a maximum of 60 clicks per injection.

    Always verify your specific pen’s click-dose specification before beginning a research protocol. Different manufacturers may use different click-weight ratios. MyReta provides click-count reference charts with each pen order.

    Using the standard 1 click = 1/6 mg specification, common research doses convert as follows:

    Target DoseClicks (any pen size)Notes
    1mg6 clicksTypical initiation dose
    2mg12 clicks 
    2.5mg15 clicks 
    5mg30 clicks 
    7.5mg45 clicks 
    10mg60 clicksMaximum per single injection

    For doses between click increments, dial to the nearest whole click. For protocols requiring greater precision, a lyophilised vial and insulin syringe — paired with the MyReta reconstitution calculator — offers more granular control.


    Retaklik Research Titration Framework

    Published Phase 2 trial data for retatrutide used a structured dose-escalation approach, starting low and increasing every four weeks. For research applications following a similar model, a typical progression might look like:

    Research WeekDoseClicks (Retaklik pen)Phase
    Weeks 1–42mg weekly12 clicksInitiation
    Weeks 5–84mg weekly24 clicksEscalation 1
    Weeks 9–128mg weekly48 clicksEscalation 2
    Week 13+Up to 12mg weeklyUp to 72 clicks*Maintenance

    *Doses above 60 clicks (10mg) require splitting across two injection sites. This is consistent with standard research practice for high-volume subcutaneous injections.

    Note: The above is a reference framework drawn from published Phase 2 clinical data. It is not a dosing recommendation. All research protocols should be designed by a qualified principal investigator with reference to published literature and ethical approval where applicable.


    Storing Your Retaklik Pen

    Unlike lyophilised peptide vials that can be frozen long-term, Retaklik pens are supplied as a ready-made solution and should be stored refrigerated at 2–8°C at all times. Keep the pen in its protective cap between uses, away from direct light.

    ConditionRecommendation
    Unopened penRefrigerated, 2–8°C — do not freeze
    In-use penRefrigerated between each use, cap replaced
    Light exposureAvoid — keep in box or sleeve
    Freeze-thaw cyclesAvoid entirely for pen-format solution

    Why Purity Matters When Sourcing Retaklik in the UK

    The UK research peptide market has grown quickly, and “Retaklik” is now appearing across several supplier catalogues. The problem is that the term is effectively unregulated as a product name — any supplier can call their retatrutide pen “Retaklik” regardless of what is actually in it.

    For meaningful research outcomes, purity is not optional. An unknown impurity profile doesn’t just raise ethical questions — it invalidates your data. What to look for from any UK Retaklik supplier:

    • HPLC purity test — confirms active compound percentage
    • Independent third-party lab testing — removes supplier self-certification bias
    • Certificate of Analysis (CoA) — batch-specific purity record you can verify
    • UK-based fulfilment — faster delivery, no customs delays

    MyReta’s Retaklik 40mg pen is independently tested by Janoshik Analytical to 99%+ HPLC purity on every batch. The Certificate of Analysis is available on request and linked from each product listing.


    Use the Free Retaklik Dose Calculator

    If your research protocol uses vial-format retatrutide alongside or instead of the Retaklik pen, MyReta’s free reconstitution calculator handles concentration, volume per dose, U-100 syringe units, and doses per vial automatically.

    The calculator also includes a Retaklik click reference chart covering 1mg, 2.5mg, 5mg, 7.5mg, and 10mg doses across 20mg, 40mg, and 60mg pen sizes — useful whether you are using pens or vials.


    Frequently Asked Questions — Retaklik UK

    What is Retaklik?

    Retaklik is a brand name for retatrutide (LY3437943) supplied in a pre-filled, multi-dose injection pen. The compound is a synthetic triple GLP-1/GIP/glucagon receptor agonist. It is supplied for research and laboratory use only in the UK.

    Is Retaklik the same as retatrutide?

    Yes, in terms of active compound. Retaklik is a pen-format presentation of retatrutide. The “klik” element refers to the click-dial dosing mechanism. The pharmacology is identical to vial-format retatrutide — the difference is how it is delivered and measured.

    How many clicks is 1mg on a Retaklik pen?

    On standard Retaklik pens, 1 click = 1/6 mg, meaning 6 clicks delivers 1mg. Always verify the click-weight specification for your specific pen, as different manufacturers may use different ratios.

    What sizes does Retaklik come in?

    Retaklik research pens are typically available in 20mg, 40mg, and 60mg fill sizes. The 40mg pen is the most widely used in UK research contexts. MyReta stocks the 40mg variant.

    How should Retaklik be stored?

    Retaklik pens should be stored refrigerated at 2–8°C and should not be frozen. Keep the pen capped between uses and away from direct light. Unlike lyophilised retatrutide vials — which can be frozen at -20°C for long-term storage — the pre-filled solution format is sensitive to freeze-thaw cycles.

    Can I buy Retaklik in the UK?

    Retaklik (retatrutide) is available in the UK from specialist research peptide suppliers for laboratory and research purposes only. It is not approved by the MHRA for clinical or consumer use. MyReta supplies independently lab-tested Retaklik 40mg pens with UK next-day delivery. For research use only.

    What is the maximum dose per Retaklik injection?

    The maximum per-injection volume on standard Retaklik pens is 60 clicks, which equals 10mg. Doses above 10mg should be split across two separate injection sites to remain within safe subcutaneous injection volumes.

    Does Retaklik need to be reconstituted?

    No. Unlike lyophilised retatrutide vials, Retaklik pens come pre-filled as a ready-to-use solution. No BAC water, no mixing, no syringe calculation needed. Simply dial your dose in clicks. If you prefer vial-format for more precise dosing control, use the MyReta free reconstitution calculator.

    Is Retaklik the same as the Eli Lilly drug?

    The compound retatrutide (LY3437943) is the same active molecule being investigated by Eli Lilly in the TRIUMPH Phase 3 trials. Research-grade Retaklik pens supply this compound for laboratory study only — they are not a licensed pharmaceutical product and are not approved for clinical use.

    How do I calculate Retaklik doses?

    For click-to-dose conversion, use: clicks × (1⁄6) = mg. For example, 30 clicks = 5mg. For vial-format retatrutide, the MyReta reconstitution calculator handles all calculations automatically, and also includes a Retaklik click reference chart.


    Source research-grade Retaklik in the UK: MyReta stocks the Retaklik 40mg pen — independently verified to 99%+ HPLC purity by Janoshik Analytical, with UK next-day delivery and 24/7 research support. For research use only.

    ]]>